Back to top

Konica Minolta and Innovation Network Corporation of Japan Close Acquisition of Ambry Genetics

October 25, 2017
No votes yet
Trending

Summary/Abstract

Ambry Genetics

Konica Minolta, Inc. (“Konica Minolta”) (TOKYO: 4902) (ISIN: JP3300600008) and Innovation Network Corporation of Japan (“INCJ”) announced the close of their joint acquisition of Ambry Genetics Corporation (“Ambry”) on October 19, 2017 (JST). Known as a pioneer and thought leader in genetic testing, Ambry is the first laboratory in the world to offer hereditary cancer panels and clinical exome sequencing. This press release features multimedia.